Perimyocarditis in Adolescents After Pfizer BioNTech COVID-19 Vaccine

U.S, 28 July 2021, Tano et al, Journal of the Pediatric Infectious Diseases Society


We describe clinical characteristics of 8 adolescents who presented over the course of 36 days to Nicklaus Children’s Hospital with perimyocarditis within 4 days of receiving a dose of BNT162b2 vaccine.

Twelve lead electrocardiogram from patient 2, demonstrating sinus rhythm with normal axis and intervals. Diffuse PR depressions and horizontal ST-segment elevations are illustrated in the magnified inset as black and white arrows, respectively. The dotted line represents the baseline. These findings are typical in patients with pericarditis. (B) A continuous telemetry strip demonstrating 2 episodes of irregular, polymorphic ventricular tachycardia from patient 4. N represents the normal QRS, and V represents the ventricular ectopic beats

Download PDF

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s